pSG059
(Plasmid
#214262)
-
PurposePaFtsH2-6xHis cloned in XbaI/NheI site in pET-28a(+)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 214262 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET-28a(+)
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5369
- Total vector size (bp) 7290
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nametLST accessory element PaFtsH2 protease of Pseudomonas aeruginosa SG17M
-
Alt nametLST: transmissible locus of stress tolerance
-
SpeciesPseudomonas aeruginosa SG17M
-
Insert Size (bp)1921
-
GenBank IDNZ_JALF00000000.1 Z695_RS45375
- Promoter T7 promoter
-
Tags
/ Fusion Proteins
- 6x His-tag (C terminal on insert)
- 6xHis-tag (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XbaI (unknown if destroyed)
- 3′ cloning site NheI (unknown if destroyed)
- 5′ sequencing primer GCGTCTAGACGACTTGCGAGGAACATTGC
- 3′ sequencing primer CGCGCTAGCTCAGTGATGATGATGATGATGTGGTGTGGACCCTTGG (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSG059 was a gift from Ute Romling (Addgene plasmid # 214262 ; http://n2t.net/addgene:214262 ; RRID:Addgene_214262) -
For your References section:
The membrane-cytoplasmic linker defines activity of FtsH proteases in Pseudomonas aeruginosa clone C. Mawla GD, Kamal SM, Cao LY, Purhonen P, Hebert H, Sauer RT, Baker TA, Romling U. J Biol Chem. 2024 Feb;300(2):105622. doi: 10.1016/j.jbc.2023.105622. Epub 2024 Jan 3. 10.1016/j.jbc.2023.105622 PubMed 38176647